Helicobacter Pylori Global Clinical Trials Review, Q1, 2011
Publisher Name » GlobalData
Published Date » 2011-02-26
No. Of Pages » 53
GlobalData's clinical trial report, “Helicobacter Pylori Global Clinical Trials Review, Q1, 2011"" provides data on the Helicobacter Pylori clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Helicobacter Pylori . It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Helicobacter Pylori This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companie
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Helicobacter Pylori 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Helicobacter Pylori 19
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Top Companies Participating in Helicobacter Pylori Therapeutics Clinical Trials 23
Prominent Drug Comparison 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Synergy Pharmaceuticals Pvt Ltd. 25
Clinical Trial Overview of Synergy Pharmaceuticals Pvt Ltd. 25
Eisai Co., Ltd. 26
Clinical Trial Overview of Eisai Co., Ltd. 26
Axcan Pharma Inc. 27
Clinical Trial Overview of Axcan Pharma Inc. 27
Novartis AG 28
Clinical Trial Overview of Novartis AG 28
Exalenz Bioscience Ltd. 29
Clinical Trial Overview of Exalenz Bioscience Ltd. 29
Clinical Trial Overview of Top Universities / Institutes / Hospitals 30
National Taiwan University Hospital 30
Clinical Trial Overview of National Taiwan University Hospital 30
Hamamatsu University School of Medicine 31
Clinical Trial Overview of Hamamatsu University School of Medicine 31
The University of Tokyo Hospital 32
Clinical Trial Overview of The University of Tokyo Hospital 32
St. Orsola Hospital 33
Clinical Trial Overview of St. Orsola Hospital 33
Aga Khan University 34
Clinical Trial Overview of Aga Khan University 34
E-Da Hospital 35
Clinical Trial Overview of E-Da Hospital 35
Showa Inan General Hospital 36
Clinical Trial Overview of Showa Inan General Hospital 36
Second Military Medical University 37
Clinical Trial Overview of Second Military Medical University 37
Seattle Institute for Biomedical and Clinical Research 38
Clinical Trial Overview of Seattle Institute for Biomedical and Clinical Research 38
Kaohsiung Veterans General Hospital. 39
Clinical Trial Overview of Kaohsiung Veterans General Hospital. 39
University of Bari 40
Clinical Trial Overview of University of Bari 40
American University of Beirut Medical Center 41
Clinical Trial Overview of American University of Beirut Medical Center 41
Mackay Memorial Hospital 42
Clinical Trial Overview of Mackay Memorial Hospital 42
Asan Medical Center 43
Clinical Trial Overview of Asan Medical Center 43
Dresden University of Technology 44
Clinical Trial Overview of Dresden University of Technology 44
Catholic University of the Sacred Heart 45
Clinical Trial Overview of Catholic University of the Sacred Heart 45
University of California, Los Angeles 46
Clinical Trial Overview of University of California, Los Angeles 46
The National Institute of Diabetes and Digestive and Kidney Diseases 47
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 47
University of Washington 48
Clinical Trial Overview of University of Washington 48
University of Louisville 49
Clinical Trial Overview of University of Louisville 49
Appendix 50
Abbreviations 50
Definitions 50
Research Methodology 51
Secondary Research 51
About GlobalData 52
Contact Us 52
Disclaimer 52
Source 52
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Helicobacter Pylori Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011* 10
Helicobacter Pylori Therapeutics Clinical Trials, Europe, Top Countries, 2011* 11
Helicobacter Pylori Therapeutics Clinical Trials, North America, Top Countries, 2011* 12
Helicobacter Pylori Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 13
Helicobacter Pylori Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011* 14
Helicobacter Pylori Therapeutics Clinical Trials, BRIC Countries, 2011* 15
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Phase, 2011* 16
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011* 17
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Helicobacter Pylori Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 19
Helicobacter Pylori Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Helicobacter Pylori Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 22
Helicobacter Pylori Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 23
Helicobacter Pylori Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 24
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Synergy Pharmaceuticals Pte Ltd., 2011* 25
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2011* 26
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Axcan Pharma Inc., 2011* 27
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011* 28
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Exalenz Bioscience Ltd., 2011* 29
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2011* 30
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamamatsu University School of Medicine, 2011* 31
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2011* 32
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Orsola Hospital, 2011* 33
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2011* 34
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by E-Da Hospital, 2011* 35
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Showa Inan General Hospital, 2011* 36
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Second Military Medical University, 2011* 37
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Institute for Biomedical and Clinical Research, 2011* 38
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaohsiung Veterans General Hospital., 2011* 39
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bari, 2011* 40
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by American University of Beirut Medical Center, 2011* 41
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Mackay Memorial Hospital, 2011* 42
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2011* 43
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2011* 44
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Catholic University of the Sacred Heart, 2011* 45
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2011* 46
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011* 47
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2011* 48
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Louisville, 2011* 49
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Helicobacter Pylori Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 10
Helicobacter Pylori Therapeutics Clinical Trials, Europe, Top Countries (%), 2011* 11
Helicobacter Pylori Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 12
Helicobacter Pylori Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011* 13
Helicobacter Pylori Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 14
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 16
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011* 17
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Helicobacter Pylori Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Helicobacter Pylori Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 21
Helicobacter Pylori Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 23
Helicobacter Pylori Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 24
GlobalData Methodology 51
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Helicobacter Pylori 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Helicobacter Pylori 19
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Top Companies Participating in Helicobacter Pylori Therapeutics Clinical Trials 23
Prominent Drug Comparison 24
Clinical Trial Profiles 25
Clinical Trial Overview of Top Companies 25
Synergy Pharmaceuticals Pvt Ltd. 25
Clinical Trial Overview of Synergy Pharmaceuticals Pvt Ltd. 25
Eisai Co., Ltd. 26
Clinical Trial Overview of Eisai Co., Ltd. 26
Axcan Pharma Inc. 27
Clinical Trial Overview of Axcan Pharma Inc. 27
Novartis AG 28
Clinical Trial Overview of Novartis AG 28
Exalenz Bioscience Ltd. 29
Clinical Trial Overview of Exalenz Bioscience Ltd. 29
Clinical Trial Overview of Top Universities / Institutes / Hospitals 30
National Taiwan University Hospital 30
Clinical Trial Overview of National Taiwan University Hospital 30
Hamamatsu University School of Medicine 31
Clinical Trial Overview of Hamamatsu University School of Medicine 31
The University of Tokyo Hospital 32
Clinical Trial Overview of The University of Tokyo Hospital 32
St. Orsola Hospital 33
Clinical Trial Overview of St. Orsola Hospital 33
Aga Khan University 34
Clinical Trial Overview of Aga Khan University 34
E-Da Hospital 35
Clinical Trial Overview of E-Da Hospital 35
Showa Inan General Hospital 36
Clinical Trial Overview of Showa Inan General Hospital 36
Second Military Medical University 37
Clinical Trial Overview of Second Military Medical University 37
Seattle Institute for Biomedical and Clinical Research 38
Clinical Trial Overview of Seattle Institute for Biomedical and Clinical Research 38
Kaohsiung Veterans General Hospital. 39
Clinical Trial Overview of Kaohsiung Veterans General Hospital. 39
University of Bari 40
Clinical Trial Overview of University of Bari 40
American University of Beirut Medical Center 41
Clinical Trial Overview of American University of Beirut Medical Center 41
Mackay Memorial Hospital 42
Clinical Trial Overview of Mackay Memorial Hospital 42
Asan Medical Center 43
Clinical Trial Overview of Asan Medical Center 43
Dresden University of Technology 44
Clinical Trial Overview of Dresden University of Technology 44
Catholic University of the Sacred Heart 45
Clinical Trial Overview of Catholic University of the Sacred Heart 45
University of California, Los Angeles 46
Clinical Trial Overview of University of California, Los Angeles 46
The National Institute of Diabetes and Digestive and Kidney Diseases 47
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 47
University of Washington 48
Clinical Trial Overview of University of Washington 48
University of Louisville 49
Clinical Trial Overview of University of Louisville 49
Appendix 50
Abbreviations 50
Definitions 50
Research Methodology 51
Secondary Research 51
About GlobalData 52
Contact Us 52
Disclaimer 52
Source 52
List of Tables
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Helicobacter Pylori Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011* 10
Helicobacter Pylori Therapeutics Clinical Trials, Europe, Top Countries, 2011* 11
Helicobacter Pylori Therapeutics Clinical Trials, North America, Top Countries, 2011* 12
Helicobacter Pylori Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 13
Helicobacter Pylori Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011* 14
Helicobacter Pylori Therapeutics Clinical Trials, BRIC Countries, 2011* 15
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Phase, 2011* 16
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011* 17
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Helicobacter Pylori Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 19
Helicobacter Pylori Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Helicobacter Pylori Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 22
Helicobacter Pylori Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 23
Helicobacter Pylori Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 24
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Synergy Pharmaceuticals Pte Ltd., 2011* 25
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2011* 26
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Axcan Pharma Inc., 2011* 27
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011* 28
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Exalenz Bioscience Ltd., 2011* 29
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2011* 30
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamamatsu University School of Medicine, 2011* 31
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2011* 32
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Orsola Hospital, 2011* 33
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2011* 34
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by E-Da Hospital, 2011* 35
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Showa Inan General Hospital, 2011* 36
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Second Military Medical University, 2011* 37
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Institute for Biomedical and Clinical Research, 2011* 38
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaohsiung Veterans General Hospital., 2011* 39
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bari, 2011* 40
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by American University of Beirut Medical Center, 2011* 41
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Mackay Memorial Hospital, 2011* 42
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2011* 43
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2011* 44
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by Catholic University of the Sacred Heart, 2011* 45
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2011* 46
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011* 47
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2011* 48
Helicobacter Pylori Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Louisville, 2011* 49
List of Figures
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Helicobacter Pylori Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 10
Helicobacter Pylori Therapeutics Clinical Trials, Europe, Top Countries (%), 2011* 11
Helicobacter Pylori Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 12
Helicobacter Pylori Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011* 13
Helicobacter Pylori Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 14
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 16
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011* 17
Helicobacter Pylori Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Helicobacter Pylori Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Helicobacter Pylori Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 21
Helicobacter Pylori Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 23
Helicobacter Pylori Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 24
GlobalData Methodology 51
Upcoming Reports:
|
AMOLED Displays Market - Global Forecast, Market Share, Size, Growth And Industry Analysis, 2011 - 2018
By - Transparency Market Research
AMOLED (active matrix organic light emitting diode) is the new technology utilized in mobiles and televisions, giving a bright and clear vision. The OLED is a technology that is characterized by a thin film coupled with the organic compounds forming the electroluminescent matter of the AMOLED. AMOLED comprise pixels of active matrix OLED that generate images when electricity flows through it which is controlled and regulated by the TFT displays present.
Owing to the developments in AMOLED displays, the declining prices and rise in the per capita income of the population,...
|
|
Rich Communications Suite Services And Subscribers Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Rich communication suite (RCS) service provides rich messaging and multimedia services for mobile subscribers. The increasing number of mobile phone users and the need for faster and effective multimedia communication are driving the market of rich communication suite services. Rich communication suite services support the RCS-enhanced variant of the standard to allow fast delivery of new services within the traditional contact list framework.
One of the major drivers of the RCS market is the increasing penetration levels of mobile subscribers in many regions, which...
|
|
Electronic Displays Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
Electronic displays convert electrical signals into visual images that are changed in real time by refreshing the memory when new information in the form of electrical signals is received. Electronic displays are proving much beneficial in numerous applications such as televisions, mobile phones, computers, among others and replacing traditional mechanical displays like galvanometers, counters, paper displays, and others.
Technological development in the field of electronics is resulting in the increasing use of electronic devices over mechanical devices. Low...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- The Future of the Haircare Market in Egypt to 2017
- The Future of the Haircare Market in Denmark to 2017
- Overview of international chemical market
- Russian market of microcredits and lending to SME in Russia
- Overview of furniture market
- Global and China Piano Industry Report, 2012-2013
- The Future of the Haircare Market in Czech Republic to 2017
- LTE Strategy 2013 - 2018
- Natural And Synthetic (Ethoxyquin, BHA, BHT) Animal Feed Antioxidants Market For Swine, Poultry, Cattle And Aquaculture - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Seed Treatment Market (Insecticides, Fungicides, Other Chemical And Nonchemical Treatment) For Corn, Soybean, Wheat, Canola, Cotton And Others - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
